LEXICON PHARMACEUTICALS, INC. (LXRX) Reports Material Event to SEC
LEXICON PHARMACEUTICALS, INC. (NASDAQ:LXRX) filed a Form 8-K with the Securities and Exchange Commission on March 05, 2026, disclosing a material event. LEXICON PHARMACEUTICALS,…
Read more
